Expansion Of Single-use Endoscopy Will Improve Hospital Efficiency

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

16 Dec 24

Updated

19 Dec 25

Views

53

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-17.3%

7D

0.3%

Loading

1Y

-17.3%

7D

0.3%

You can edit this narrative until Dec 20 4:05 PM. Then, changes will post as Updates.

Author's Valuation

DKK 114.7923.6% undervalued

AnalystConsensusTarget Fair Value

Shared on 19 Dec 25

Fair value Decreased 0.69%

AMBU B: Dividend And Share Buybacks Will Drive Future Upside Potential

Analysts have trimmed their price target for Ambu slightly, lowering fair value by about 1 dollar per share as modestly slower expected revenue growth and profit margins are only partly offset by a slightly higher future P/E multiple and lower discount rate. What's in the News Ambu has launched a new share repurchase program starting December 10, 2025, allowing buybacks of up to 10% of its share capital under a mandate valid until December 13, 2027 (company announcement) The company announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with an ex date of December 4 and record date of December 5, 2025 (company announcement) For fiscal 2025/26, Ambu issued guidance for 10% to 13% organic growth and an EBIT margin of 12% to 14%, or 14% to 16% excluding roughly 2 percentage points of tariff impacts (company guidance) Ambu reaffirmed its 2024/25 financial guidance, maintaining expectations for 12% to 14% organic revenue growth (company guidance) Valuation Changes Fair Value Estimate edged down slightly from DKK 115.59 to DKK 114.79 per share, reflecting a modestly lower fundamental valuation.

Shared on 05 Dec 25

AMBU B: Dividend Initiation And Margin Outlook Will Support Future Upside

Analysts have modestly raised their price target on Ambu by DKK 0.00 to reflect a slightly higher discount rate and updated profitability assumptions, while maintaining largely unchanged views on long term growth and valuation multiples. What's in the News Ambu A/S announced an annual dividend of DKK 0.41 per share, payable on December 8, 2025, with ex-date December 4 and record date December 5, 2025 (Key Developments).

Shared on 21 Nov 25

Fair value Decreased 4.80%

AMBU B: Improved Margins And Dividend Outlook Will Support Bullish Momentum

Analysts have slightly lowered their fair value price target for Ambu from DKK 121.41 to DKK 115.59, citing modest decreases in projected revenue growth and profit margin expectations. What's in the News Ambu A/S announced an annual dividend of DKK 0.4100 per share.

Shared on 06 Nov 25

Fair value Decreased 7.10%

AMBU B: Higher Profit Margins Will Drive Hospital Efficiency Improvements

Analysts have revised their fair value estimate for Ambu down from DKK 130.70 to DKK 121.41. They cite a slightly higher discount rate, even though profit margin and revenue growth projections have improved.

Shared on 01 May 25

Fair value Decreased 11%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Increased 13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Decreased 11%

Shared on 02 Apr 25

Fair value Increased 2.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

Fair value Increased 11%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Decreased 11%

AnalystConsensusTarget has decreased revenue growth from 12.8% to 11.1%, increased discount rate from 5.0% to 5.6% and decreased shares outstanding growth rate from 0.0% to -0.0%.

AnalystConsensusTarget Fair Value

DKK 114.79

23.6% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

10.02%

Medical Equipment revenue growth rate

7.21%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

5.79%

Calculation

DKK 1.18b

Earnings '28

x

30.75x

PE Ratio '28

=

DKK 36.27b

Market Cap '28

DKK 36.27b

Market Cap '28

/

267.05m

No. shares '28

=

DKK 135.81

Share Price '28

DKK 135.81 Share Price '28

Discounted to 2025 @ 5.77% p.a.

=

DKK 114.76

Fair Value '25